4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-22-005681
Chief Financial Officer sold 4,800 shares at an average $30.01 ($144,028)
From the SEC's structured data for this filing
Trades in this filing
Vasista Vittal · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-07-13 | Sale : show line 1 in the form | −4,332 | $30.01 | $129,988 | 158,108 | D |
| 2022-07-14 | Sale : show line 2 in the form | −468 | $30.00 | $14,040 | 157,640 | D |
| Open-market sales · 4,800 sh · avg $30.01 · $144,028 | ||||||
Loading xslF345X03/primarydocument.xml…